EP0269712A4 - Peptides involved in the pathogenesis of hiv infection. - Google Patents
Peptides involved in the pathogenesis of hiv infection.Info
- Publication number
- EP0269712A4 EP0269712A4 EP19870903968 EP87903968A EP0269712A4 EP 0269712 A4 EP0269712 A4 EP 0269712A4 EP 19870903968 EP19870903968 EP 19870903968 EP 87903968 A EP87903968 A EP 87903968A EP 0269712 A4 EP0269712 A4 EP 0269712A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- pathogenesis
- hiv infection
- peptides involved
- peptides
- involved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000031886 HIV Infections Diseases 0.000 title 1
- 208000037357 HIV infectious disease Diseases 0.000 title 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 title 1
- 230000008506 pathogenesis Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87362186A | 1986-06-12 | 1986-06-12 | |
US873621 | 1986-06-12 | ||
US4193687A | 1987-04-24 | 1987-04-24 | |
US41936 | 1987-04-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0269712A1 EP0269712A1 (en) | 1988-06-08 |
EP0269712A4 true EP0269712A4 (en) | 1990-06-26 |
Family
ID=26718709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19870903968 Withdrawn EP0269712A4 (en) | 1986-06-12 | 1987-06-09 | Peptides involved in the pathogenesis of hiv infection. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0269712A4 (en) |
JP (1) | JPH01501547A (en) |
AU (1) | AU617088B2 (en) |
NZ (1) | NZ220653A (en) |
WO (1) | WO1987007616A1 (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5126399A (en) * | 1986-04-30 | 1992-06-30 | Board Of Regents, The University Of Texas System | Methods and compositions for the preparation and use of site-directed immunologic reagents |
EP0255190A3 (en) * | 1986-08-01 | 1990-08-29 | Repligen Corporation | Recombinant polypeptides and their uses, inclusing assay for aids virus |
US5166050A (en) * | 1986-08-20 | 1992-11-24 | Bristol-Myers Squibb Company | Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections |
US5976541A (en) * | 1988-01-26 | 1999-11-02 | The United States Of America As Represented By The Department Of Health And Human Services | Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope |
NO881151L (en) * | 1987-03-27 | 1988-09-28 | Syntello Ab | SYNTHETIC HIV-1 ANTIGEN. |
FI872409A0 (en) * | 1987-05-29 | 1987-05-29 | Labsystems Oy | FOERFARANDE FOER DETEKTERING AV HIV-1 MOTKROPPAR. |
US5820865A (en) * | 1988-01-26 | 1998-10-13 | The United States Of America As Represented By The Department Of Health And Human Services | Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides |
JP2569185B2 (en) * | 1988-01-26 | 1997-01-08 | アメリカ合衆国 | Synthetic antigen eliciting anti-HIV response |
US5763160A (en) * | 1988-02-12 | 1998-06-09 | United Biomedical, Inc. | Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines |
CA1341285C (en) * | 1988-02-12 | 2001-08-14 | Chang Yi Wang | Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
EP0339504A3 (en) * | 1988-04-26 | 1990-09-12 | The Du Pont Merck Pharmaceutical Company | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |
US5562905A (en) * | 1988-04-26 | 1996-10-08 | E. I. Du Pont De Nemours And Company | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |
WO1990003984A1 (en) * | 1988-10-03 | 1990-04-19 | Repligen Corporation | Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids |
CA2051107A1 (en) * | 1989-04-25 | 1990-10-26 | William N. Sun | Antibodies specific for cd4-binding domain of hiv |
US6309880B1 (en) * | 1989-04-25 | 2001-10-30 | Tanox, Inc. | Antibodies specific for CD4-binding domain of HIV-1 |
GB8912496D0 (en) * | 1989-05-31 | 1989-07-19 | Medical Res Council | Vaccines |
US5346989A (en) * | 1990-08-22 | 1994-09-13 | Syntello Vaccine Development Kb | Peptides for use in induction of T cell activation against HIV-1 |
HU9300877D0 (en) * | 1990-09-27 | 1993-06-28 | Syntello Vaccine Dev Kb | Method for producing proteines applicables by injection and inducing anti-bodies having neutralizing effect against virus of human immun insufficiency |
US5840313A (en) * | 1990-09-27 | 1998-11-24 | Syntello Vaccine Development Kb | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
AU662534B2 (en) * | 1991-06-03 | 1995-09-07 | Syntello Vaccine Development Ab | Peptides for use in induction of T cell activation against HIV-1 |
US5444044A (en) * | 1992-03-26 | 1995-08-22 | New York Blood Center | Synthetic polypeptides as inhibitors of HIV-1 |
DE69311764T2 (en) * | 1992-05-14 | 1998-02-05 | Polymun Scient Immunbio Forsch | Peptides that induce antibodies that neutralize genetically divergent HIV-1 isolations |
AU667578B2 (en) * | 1992-08-27 | 1996-03-28 | Deakin Research Limited | Retro-, inverso-, and retro-inverso synthetic peptide analogues |
US5464933A (en) * | 1993-06-07 | 1995-11-07 | Duke University | Synthetic peptide inhibitors of HIV transmission |
DE4405810A1 (en) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Peptides derived from a retrovirus from the HIV group and their use |
FR2717081B1 (en) * | 1994-03-14 | 1996-06-21 | Centre Nat Rech Scient | Retropeptides, antibodies to the latter, and their uses for vaccination and in vitro diagnosis. |
CA2235168A1 (en) * | 1995-10-20 | 1997-04-24 | Duke University | Synthetic vaccine for protection against human immunodeficiency virus infection |
US6749856B1 (en) | 1997-09-11 | 2004-06-15 | The United States Of America, As Represented By The Department Of Health And Human Services | Mucosal cytotoxic T lymphocyte responses |
US6281331B1 (en) * | 1998-03-23 | 2001-08-28 | Trimeris, Inc. | Methods and compositions for peptide synthesis |
NZ507083A (en) * | 1998-03-23 | 2003-10-31 | Trimeris Inc | Methods and compositions for peptide synthesis, in particular T-20 (DP-178) and T-20-like peptides |
ES2366185T3 (en) * | 2003-04-11 | 2011-10-18 | Institut Pasteur | SYNTHETIC PEPTIDES VACCINES FOR HIV: THE EPDOPE OF CBD AS AN EFFECTIVE IMMUNOGEN TO PROVIDE WIDE NEUTRALIZING ANTIBODIES AGAINST HIV. |
US20060205070A1 (en) * | 2004-01-13 | 2006-09-14 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | HIV TEV compositions and methods of use |
EP1714153A2 (en) * | 2004-02-06 | 2006-10-25 | I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale | A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual |
WO2007039458A2 (en) * | 2005-09-21 | 2007-04-12 | Cytos Biotechnology Ag | Hiv peptide conjugates and uses thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986002383A1 (en) * | 1984-10-18 | 1986-04-24 | Institut Pasteur | Envelope antigens of lymphadenopathy associated virus and their applications |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4629783A (en) * | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
GB8525615D0 (en) * | 1985-10-17 | 1985-11-20 | Hoffmann La Roche | Polypeptides |
US4772547A (en) * | 1986-02-03 | 1988-09-20 | Hoffmann-La Roche Inc. | HTLV-III envelope peptides |
-
1987
- 1987-06-09 JP JP62503612A patent/JPH01501547A/en active Pending
- 1987-06-09 WO PCT/US1987/001294 patent/WO1987007616A1/en not_active Application Discontinuation
- 1987-06-09 AU AU75404/87A patent/AU617088B2/en not_active Ceased
- 1987-06-09 EP EP19870903968 patent/EP0269712A4/en not_active Withdrawn
- 1987-06-11 NZ NZ220653A patent/NZ220653A/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986002383A1 (en) * | 1984-10-18 | 1986-04-24 | Institut Pasteur | Envelope antigens of lymphadenopathy associated virus and their applications |
Non-Patent Citations (3)
Title |
---|
Bio/Technology, Vol. 3, October 1985, pages 905-909, TSE WEN CHANG et al.: "Detection of antibodies to human T-cell lymphotropic virus- III (HTLV-III) with an immunoassay employing a recombinant Escherichia Coli-derived viral antigenic peptide", whole document. * |
Science, Vol. 231, March 28, 1986, pages 1556-1559, R.C. KENNEDY et al.: "Antiserum to a synthetic peptide recognized the HTLV-III envelope glycoprotein", whole document. * |
See also references of WO8707616A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP0269712A1 (en) | 1988-06-08 |
JPH01501547A (en) | 1989-06-01 |
AU617088B2 (en) | 1991-11-21 |
WO1987007616A1 (en) | 1987-12-17 |
AU7540487A (en) | 1988-01-11 |
NZ220653A (en) | 1990-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0269712A4 (en) | Peptides involved in the pathogenesis of hiv infection. | |
FI873117A (en) | HOPVIKBAR IHAOLIG ARTICLE. | |
FI880765A0 (en) | FOER ENGAONGSANVAENDNING AVSEDD VAETSKEABSORBERANDE ARTICLE. | |
DE3778287D1 (en) | PEPTIDIC COMPOSITION. | |
DE3774374D1 (en) | Wound-healing preparations. | |
NO873080D0 (en) | MICROBICID PREPARATION. | |
DE3788408D1 (en) | IMMUNE REINFORCEMENT. | |
DE3774594D1 (en) | COMPOSITE BODY. | |
FI880020A (en) | VAESENTIGEN REN CYTOTOXITET UTLOESANDE FAKTOR. | |
NO864588D0 (en) | FILTER BODY. | |
NO871001D0 (en) | Contraceptive. | |
DE3671886D1 (en) | COMPOSED BODY. | |
NO874193D0 (en) | PHARMACEUTICAL PREPARATIONS. | |
DE3786301D1 (en) | COMBINED VACCINE. | |
ES2015548B3 (en) | BUTTON. | |
DE3766147D1 (en) | GRINDING BODY. | |
DE3764163D1 (en) | BUCKLE. | |
EP0338092A4 (en) | Anti-hiv agent. | |
OA09308A (en) | Anti-HIV agent. | |
ES2018552B3 (en) | INTERENGRANABLE ARTICLE. | |
EP0266401A4 (en) | Vaccine. | |
ES2014488B3 (en) | MERCAPTOALCOHOLES PREPARATION PROCEDURE. | |
NO875019D0 (en) | ANTICARIOGENIC PREPARATIONS. | |
MX9203757A (en) | DERIVED FROM ERYTHROMYCIN AND THE PREPARATION AND USE OF THE SAME. | |
ZA878917B (en) | 1-aryloxy-3-amino-2-propanols,the preparation and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19880219 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: GILBERT, WALTER Owner name: BIOGEN, INC. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19900626 |
|
17Q | First examination report despatched |
Effective date: 19911004 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19920415 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: RAMACHANDRAN, KUZHALMANNAM, L. Inventor name: SATO, VICKI, L. Inventor name: FISHER, RICHARD, A. |